Samia Arifi Selected Research

Ototoxicity

3/2014

Oxaliplatin-induced ototoxicity in adjuvant setting for colorectal cancer: unusual side effect.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Samia Arifi Research Topics

Disease

10	Neoplasms (Cancer) 10/2022 - 01/2008
4	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 05/2022 - 01/2008
3	Carcinoma (Carcinomatosis) 05/2022 - 01/2015
3	Breast Neoplasms (Breast Cancer) 09/2020 - 04/2009
2	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 01/2022
2	Disease Progression 01/2015 - 05/2008
1	Giant Cell Tumors (Giant Cell Tumor) 10/2022
1	Frailty 08/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Amenorrhea 09/2020
1	COVID-19 07/2020
1	Triple Negative Breast Neoplasms 01/2020
1	Dermatofibrosarcoma 01/2019
1	Dermatomyositis (Dermatopolymyositis) 01/2019
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2017
1	Lung Neoplasms (Lung Cancer) 01/2015
1	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 11/2014
1	Uterine Hemorrhage (Uterine Bleeding) 07/2014
1	Embryonal Rhabdomyosarcoma 07/2014
1	Colorectal Neoplasms (Colorectal Cancer) 03/2014
1	Ototoxicity 03/2014
1	Neoplasm Metastasis (Metastasis) 01/2014
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2013
1	Melanoma (Melanoma, Malignant) 09/2012
1	Pathologic Complete Response 09/2010
1	Fibrosarcoma 09/2010
1	Dermatitis 04/2009
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2008

Drug/Important Bio-Agent (IBA)

7	Imatinib Mesylate (Gleevec)FDA Link 05/2022 - 01/2008
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2015 - 01/2013
1	Denosumab FDA Link 10/2022
1	AntibodiesIBA 01/2022
1	CytokinesIBA 01/2022
1	Cancer VaccinesIBA 01/2022
1	GadoliniumIBA 07/2021
1	AsbestosIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	VaccinesIBA 07/2020
1	Estrogen ReceptorsIBA 01/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2020
1	human ERBB2 proteinIBA 01/2020
1	Carboplatin (JM8)FDA LinkGeneric 01/2015
1	CarbohydratesIBA 01/2015
1	Fetal Proteins (Fetoprotein)IBA 01/2015
1	AntigensIBA 01/2015
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 11/2014
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2014
1	Cisplatin (Platino)FDA LinkGeneric 09/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2010
1	AnthracyclinesIBA 04/2009
1	Tyrosine Kinase InhibitorsIBA 12/2008
1	Sunitinib (Sutent)FDA Link 12/2008
1	Phosphotransferases (Kinase)IBA 01/2008

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 01/2022 - 07/2014
4	Therapeutics 01/2022 - 01/2013
4	Radiotherapy 01/2022 - 04/2009
2	Chemoradiotherapy 05/2022 - 04/2009
2	Neoadjuvant Therapy 05/2022 - 09/2010
2	Immunotherapy 01/2022 - 01/2021
2	Combined Modality Therapy 01/2021 - 01/2017
1	Precision Medicine 01/2023
1	Induction Chemotherapy 05/2022
1	Nephrectomy 01/2015
1	Radical Mastectomy 01/2014
1	Combination Drug Therapy (Combination Chemotherapy) 01/2013
1	Adjuvant Chemotherapy 09/2010